Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406) Meeting Abstract
| Authors: | Kopetz, S.; McDonough, S. L.; Lenz, H. J.; Magliocco, A. M.; Atreya, C. E.; Diaz, L. A.; Allegra, C. J.; Raghav, K. P. S.; Morris, V. K.; Wang, S. E.; Lieu, C. H.; Guthrie, K. A.; Hochster, H. S. |
| Abstract Title: | Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 168s |
| Language: | English |
| ACCESSION: | WOS:000411895706176 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.3505 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3505 -- Source: Wos |
